1.5 Abstract in rivista

1.5 Abstract in rivista: [2157] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1.801 a 1.820 di 2.157

Significant impact of FDG plasma kinetics and uptake time on tumor SUV in oncology clinical trials

2014-01-01 Ni, W; Vriens, D; de Geus-Oei, Lf; Oyen, W; Bengtsson, T; de Crespigny, A; Sanabria, S

Dipyridamole protects against ischemia and reperfusion injury in two different human models

2011-01-01 Wouters, Cw; Meijer, P; Wouterse, A; Boerman, Oc; Kievit, Pc; Van Swieten, Ha; Pickkers, P; Smits, P; Oyen, W; Rongen, Ga

Imaging of IGF-1R expression with In-111-labeled F(ab ')(2) fragments compared to intact IgG in a mouse model for triple negative breast cancer

2011-01-01 Heskamp, S; van Laarhoven, Hwm; Bouwman, Wh; Oyen, W; van der Graaf, Wta; Boerman, Oc

PET, CT and MRI for the detection of experimental colorectal liver metastases: An exploratory study

2011-01-01 de Jong, G; Hendriks, T; Gotthardt, M; Visser, E; Oyen, W; Boerman, Oc

Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases; A prospective study

2007-01-01 Ruers, T; Joosten, J; Wiering, B; Wobbes, V; Dekker, H; Oyen, W; Krabbe, P; Punt, K

In-111-anti-F4/80 for in vivo tracking of tumor associated macrophages

2014-01-01 Terry, S; Boerman, O; Gerrits, D; Metselaar, J; Lehmann, S; Gerdes, C; Oyen, W; Abiraj, K

Molecular imaging for personalised treatment of cancer

2014-01-01 Oyen, W

Imaging of epidermal growth factor receptor expression in head and neck cancer xenografts with ultra high resolution single- photon emission computed tomography (USPECT) with 111In-labeled Cetuximab-F(ab ')2

2012-01-01 van Dijk, L; Franssen, G; Stegeman, H; Oyen, W; Kaanders, H; Boerman, O; Bussink, J

Phase I clinical study of pretargeted radioimmunotherapy (PRIT) in patients with colorectal cancer (CRC): An update

2012-01-01 Schoffelen, R; van der Graaf, W; Sharkey, R; Boerman, O; Visser, E; Mcbride, W; Rossi, E; Chang, Ch; Goldenberg, D; Oyen, W

Multi-modality imaging to predict response to systemic treatment in colorectal cancer: Preliminary results

2012-01-01 Heijmen, L; de Geus-Oei, Lf; ter Voert, E; Heerschap, A; van Spronsen, Dj; Oyen, W; Punt, C; van Laarhoven, H

Biodistribution of In-111-labeled D2B IgG, F(ab')(2) and Fab fragments in nude mice bearing human prostate cancer xenografts

2012-01-01 Lutje, S; Franssen, G; Helfrich, W; Fracasso, G; Colombatti, M; van Rij, C; Oyen, W; Boerman, O

The effect of bevacizumab on targeting of anti-epidermal growth factor receptor and anti-insulin-like growth factor 1 receptor antibodies.

2012-01-01 Heskamp, S; Boerman, Oc; Molkenboer-Kuenen, Jdm; Oyen, W; Van der Graaf, Wta; Van Laarhoven, Hwm

The value of FDG-PET/CT in diagnosis and during follow-up of 273 patients with chronic Q fever

2016-01-01 Kouijzer, I; Aarntzen, E; Kampschreur, L; Wever, P; Hoekstra, C; van Kasteren, M; de Jager-Leclerque, M; Nabuurs-Franssen, M; Wegdam-Blans, M; de Geus-Oei, L; Oyen, W; Bleeker-Rovers, C

A direct comparison of four different Ga-68-labeled RGD peptides for PET/CT imaging of angiogenesis

2017-01-01 Lobeek, D; Terry, Sya; Franssen, Gm; Ma, Mt; Wester, H; Decristoforo, S; Oyen, W; Boerman, Oc; Rijpkema, M

Targeted dual-modality image-guided surgery using monoclonal antibodies in preclinical tumor models

2014-01-01 Hekman, M; Rijpkema, M; Lutje, S; Muselaers, S; Bos, D; Franssen, G; Oyen, W; Boerman, O

Immuno-SPECT monitoring of pretargeted radioimmunotherapy with a bispecific antibody in athymic mice with intraperitoneal human colon cancer lesions: Pretargeting theranostics

2012-01-01 Schoffelen, R; van der Graaf, Wta; Sharkey, Rm; Franssen, Gm; Mcbride, W; Chang, C; Bos, Dl; Goldenberg, Dm; Oyen, W; Boerman, Oc

FLT-PET during (chemo)radiotherapy in head and neck cancer patients: an early Predictor for the Long-term outcome

2012-01-01 Hoeben, Baw; Troost, Egc; van Herpen, Cm; Bussink, J; Oyen, W; Kaanders, Jham

A PHASE IB CLINICAL STUDY WITH 18F-FDG-PET RESPONSE EVALUATION OF THE COMBINATION OF TEMSIROLIMUS (T) AND PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) IN BREAST, ENDOMETRIAL AND OVARIAN CANCER

2012-01-01 Sonderen, Mj; Desar, Ime; De Geus-Oei, L; van der Graaf, Wta; Oyen, W; Ottevanger, Pb; van Herpen, Cml

Scintigraphic evaluation of experimental chronic osteomyelitis.

1998-01-01 Dams, Etm; Nijhof, Mw; Boerman, Oc; Laverman, P; Storm, G; Lemmens, Jam; van der Meer, Jwm; Corstens, Fhm; Oyen, W

Cost-effectiveness of FDG-PET for the detection of unknown primary tumours presenting as a lymph node metastasis in the neck

2007-01-01 Roodenburg, Jln; Pruim, J; Prost, Wj; de Bree, R; van den Hoogen, Fja; van der Werff-Regelink, G; Hoekstra, Os; Marres, Ham; van der Laan, Bfam; Oyen, W

Titolo	Data di pubblicazione	Autore(i)
Significant impact of FDG plasma kinetics and uptake time on tumor SUV in oncology clinical trials	1-gen-2014	Ni, W; Vriens, D; de Geus-Oei, Lf; Oyen, W; Bengtsson, T; de Crespigny, A; Sanabria, S
Dipyridamole protects against ischemia and reperfusion injury in two different human models	1-gen-2011	Wouters, Cw; Meijer, P; Wouterse, A; Boerman, Oc; Kievit, Pc; Van Swieten, Ha; Pickkers, P; Smits, P; Oyen, W; Rongen, Ga
Imaging of IGF-1R expression with In-111-labeled F(ab ')(2) fragments compared to intact IgG in a mouse model for triple negative breast cancer	1-gen-2011	Heskamp, S; van Laarhoven, Hwm; Bouwman, Wh; Oyen, W; van der Graaf, Wta; Boerman, Oc
PET, CT and MRI for the detection of experimental colorectal liver metastases: An exploratory study	1-gen-2011	de Jong, G; Hendriks, T; Gotthardt, M; Visser, E; Oyen, W; Boerman, Oc
Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases; A prospective study	1-gen-2007	Ruers, T; Joosten, J; Wiering, B; Wobbes, V; Dekker, H; Oyen, W; Krabbe, P; Punt, K
In-111-anti-F4/80 for in vivo tracking of tumor associated macrophages	1-gen-2014	Terry, S; Boerman, O; Gerrits, D; Metselaar, J; Lehmann, S; Gerdes, C; Oyen, W; Abiraj, K
Molecular imaging for personalised treatment of cancer	1-gen-2014	Oyen, W
Imaging of epidermal growth factor receptor expression in head and neck cancer xenografts with ultra high resolution single- photon emission computed tomography (USPECT) with 111In-labeled Cetuximab-F(ab ')2	1-gen-2012	van Dijk, L; Franssen, G; Stegeman, H; Oyen, W; Kaanders, H; Boerman, O; Bussink, J
Phase I clinical study of pretargeted radioimmunotherapy (PRIT) in patients with colorectal cancer (CRC): An update	1-gen-2012	Schoffelen, R; van der Graaf, W; Sharkey, R; Boerman, O; Visser, E; Mcbride, W; Rossi, E; Chang, Ch; Goldenberg, D; Oyen, W
Multi-modality imaging to predict response to systemic treatment in colorectal cancer: Preliminary results	1-gen-2012	Heijmen, L; de Geus-Oei, Lf; ter Voert, E; Heerschap, A; van Spronsen, Dj; Oyen, W; Punt, C; van Laarhoven, H
Biodistribution of In-111-labeled D2B IgG, F(ab')(2) and Fab fragments in nude mice bearing human prostate cancer xenografts	1-gen-2012	Lutje, S; Franssen, G; Helfrich, W; Fracasso, G; Colombatti, M; van Rij, C; Oyen, W; Boerman, O
The effect of bevacizumab on targeting of anti-epidermal growth factor receptor and anti-insulin-like growth factor 1 receptor antibodies.	1-gen-2012	Heskamp, S; Boerman, Oc; Molkenboer-Kuenen, Jdm; Oyen, W; Van der Graaf, Wta; Van Laarhoven, Hwm
The value of FDG-PET/CT in diagnosis and during follow-up of 273 patients with chronic Q fever	1-gen-2016	Kouijzer, I; Aarntzen, E; Kampschreur, L; Wever, P; Hoekstra, C; van Kasteren, M; de Jager-Leclerque, M; Nabuurs-Franssen, M; Wegdam-Blans, M; de Geus-Oei, L; Oyen, W; Bleeker-Rovers, C
A direct comparison of four different Ga-68-labeled RGD peptides for PET/CT imaging of angiogenesis	1-gen-2017	Lobeek, D; Terry, Sya; Franssen, Gm; Ma, Mt; Wester, H; Decristoforo, S; Oyen, W; Boerman, Oc; Rijpkema, M
Targeted dual-modality image-guided surgery using monoclonal antibodies in preclinical tumor models	1-gen-2014	Hekman, M; Rijpkema, M; Lutje, S; Muselaers, S; Bos, D; Franssen, G; Oyen, W; Boerman, O
Immuno-SPECT monitoring of pretargeted radioimmunotherapy with a bispecific antibody in athymic mice with intraperitoneal human colon cancer lesions: Pretargeting theranostics	1-gen-2012	Schoffelen, R; van der Graaf, Wta; Sharkey, Rm; Franssen, Gm; Mcbride, W; Chang, C; Bos, Dl; Goldenberg, Dm; Oyen, W; Boerman, Oc
FLT-PET during (chemo)radiotherapy in head and neck cancer patients: an early Predictor for the Long-term outcome	1-gen-2012	Hoeben, Baw; Troost, Egc; van Herpen, Cm; Bussink, J; Oyen, W; Kaanders, Jham
A PHASE IB CLINICAL STUDY WITH 18F-FDG-PET RESPONSE EVALUATION OF THE COMBINATION OF TEMSIROLIMUS (T) AND PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) IN BREAST, ENDOMETRIAL AND OVARIAN CANCER	1-gen-2012	Sonderen, Mj; Desar, Ime; De Geus-Oei, L; van der Graaf, Wta; Oyen, W; Ottevanger, Pb; van Herpen, Cml
Scintigraphic evaluation of experimental chronic osteomyelitis.	1-gen-1998	Dams, Etm; Nijhof, Mw; Boerman, Oc; Laverman, P; Storm, G; Lemmens, Jam; van der Meer, Jwm; Corstens, Fhm; Oyen, W
Cost-effectiveness of FDG-PET for the detection of unknown primary tumours presenting as a lymph node metastasis in the neck	1-gen-2007	Roodenburg, Jln; Pruim, J; Prost, Wj; de Bree, R; van den Hoogen, Fja; van der Werff-Regelink, G; Hoekstra, Os; Marres, Ham; van der Laan, Bfam; Oyen, W

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1.801 a 1.820 di 2.157

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext2104
reserved51
open2